BRIEF published on 02/10/2026 at 18:05, 3 months 6 days ago Kalray Ends Equity Line Agreement with IRIS Financing IRIS Kalray Data Processing Equity Line
BRIEF published on 02/10/2026 at 18:05, 3 months 6 days ago Kalray met fin à son accord de ligne de crédit avec IRIS Financement Informatique IRIS Kalray Ligne De Crédit Sur Fonds Propres
BRIEF published on 02/10/2026 at 18:05, 3 months 6 days ago Roche Bobois poursuit son programme de rachat d'actions Rachat D'actions Euronext Structure De Capital Roche Bobois Programme Autorisé
BRIEF published on 02/10/2026 at 18:05, 3 months 6 days ago Strategic Licensing Agreement for Rare Disease Treatments Rare Diseases Strategic Agreement Licensing Deal THX Pharma Biocodex
BRIEF published on 02/10/2026 at 18:05, 3 months 6 days ago Accord Stratégique entre THX Pharma et Biocodex pour trois Maladies Rares Maladies Rares Accord De Licence THX Pharma Biocodex Batten-1 Et TX01
BRIEF published on 02/10/2026 at 18:05, 3 months 6 days ago Roche Bobois continues its share buyback program Euronext Share Buyback Capital Structure Roche Bobois Authorized Program
BRIEF published on 02/10/2026 at 18:05, 3 months 6 days ago Bilan annuel du contrat de liquidité de U10 Corp en 2025 Transactions TP ICAP Liquidité 2025 U10 Corp
BRIEF published on 02/10/2026 at 18:05, 3 months 6 days ago Accord de licence stratégique pour les traitements des maladies rares Accord Stratégique Maladies Rares Accord De Licence THX Pharma Biocodex
BRIEF published on 02/10/2026 at 18:05, 3 months 6 days ago Strategic agreement between THX Pharma and Biocodex for three rare diseases Rare Diseases License Agreement THX Pharma Biocodex Batten-1 And TX01
BRIEF published on 02/10/2026 at 18:05, 3 months 6 days ago Annual review of U10 Corp's liquidity contract in 2025 Liquidity Transactions TP ICAP 2025 U10 Corp
Published on 05/16/2026 at 01:15, 1 day 14 hours ago Findev Inc. Announces a New Member of the Board of Directors
Published on 05/16/2026 at 00:00, 1 day 15 hours ago Onco-Innovations Strengthens Quality Testing for Lead PNKP Inhibitor Drug Candidate
Published on 05/15/2026 at 23:10, 1 day 16 hours ago Golden Minerals Reports First Quarter 2026 Financial Results
Published on 05/16/2026 at 16:08, 23 hours 43 minutes ago The publication of the audited financial statements for 2025 will be postponed to 12 June 2026 – management does not expect any significant changes to the figures already published
Published on 05/15/2026 at 20:10, 1 day 19 hours ago CPIPG Communication Concerning Voluntary Offer on NEXT RE Shares – Provisional Results Announcement
Published on 05/15/2026 at 18:10, 1 day 21 hours ago Virtual Science AI launches first AI-driven competitor activity tracking platform to support pharma asset launch success
Published on 05/15/2026 at 15:08, 2 days ago Notice of exercise of early redemption option of the subordinated note ISIN : FR0010203026
Published on 05/15/2026 at 15:00, 2 days ago Exercice de l’option de remboursement de l'instrument subordonné FR0010203026
Published on 05/15/2026 at 10:09, 2 days 5 hours ago Groupe Crit : Modalités de mise à disposition des documents préparatoires à l’Assemblée Générale Mixte du 05 juin 2026.
Published on 05/14/2026 at 09:03, 3 days 6 hours ago Coup d'envoi pour les carrières dans l'esport : 65% de la population mondiale réclame plus de formations et de parcours professionnels pour le jeu vidéo de compétition
Published on 05/13/2026 at 18:02, 3 days 21 hours ago ALTAREA : Assemblée Générale Mixte du 4 juin 2026 MODALITES DE MISE A DISPOSITION DES DOCUMENTS PREPARATOIRES
